Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain (Q41728363)

8 October 2017

title

Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain (English)

1 reference

8 October 2017

author

Valentín Cuervas-Mons

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

María T Serrano

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Magda Guilera

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Itxarone Bilbao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Magdalena Salcedo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Miguel Angel Gómez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Carlos Jimenez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Javier Castroagudín

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Joan Fabregat

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Carolina Almohalla

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Ignacio Herrero

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Alejandra Otero

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Angel Rubín

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Manuel Miras

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Juan Rodrigo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Gonzalo Crespo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Manuel De la Mata

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Javier Bustamante

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

M Luisa Gonzalez-Dieguez

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Antonia Moreno

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

Isidoro Narvaez

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

EVEROLIVER study group

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

publication date

1 August 2015

1 reference

8 October 2017

published in

Liver Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

1056-1065

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25990257 AND SRC:MED&resulttype=core&format=json

Recent advances in liver transplantation

11 June 2020

cites work

1 reference

End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment

21 January 2018

1 reference

Outcomes after liver transplantation: chronic kidney disease

21 January 2018

1 reference

m-TOR inhibitors: What role in liver transplantation?

21 January 2018

1 reference

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial

21 January 2018

1 reference

Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study

21 January 2018

1 reference

Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function

21 January 2018

1 reference

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

21 January 2018

1 reference

Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis

21 January 2018

1 reference

Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial

21 January 2018

1 reference

Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function.

21 January 2018

1 reference

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

Antitumor efficacy of mammalian target of rapamycin inhibitor therapy in liver transplant recipients with oncological disease: a case-control study.

21 January 2018

1 reference

The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence

21 January 2018

1 reference

Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression

21 January 2018

1 reference

Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis

21 January 2018

1 reference

Indications and management of everolimus after liver transplantation.

21 January 2018

1 reference

Management of hepatocellular carcinoma recurrence after liver transplantation.

21 January 2018

1 reference

Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms.

21 January 2018

1 reference

Everolimus monotherapy or combined therapy in liver transplantation: indications and results.

21 January 2018

1 reference

Efficacy, tolerance, and safety of mammalian target of rapamycin inhibitors as rescue immunosuppressants in liver transplantation.

21 January 2018

1 reference

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.

21 January 2018

1 reference

Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation

21 January 2018

1 reference

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT.

21 January 2018

1 reference